Beware the low urine pH—the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes
- 13 November 2011
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 14 (4), 299-303
- https://doi.org/10.1111/j.1463-1326.2011.01519.x
Abstract
There is an increased prevalence of nephrolithiasis and an increase in the incidence of renal colic in patients with diabetes, obesity, hypertension and insulin resistance because of an increased frequency of uric acid crystallization. Uric acid crystallization occurs in the milieu of an acid urine and is not due to hyperuricosuria as with insulin resistance, urinary uric acid levels are generally decreased because of increased renal tubular reabsorption. However, in the presence of insulin resistance, there is decreased renal tubular generation of ammonia and increased sodium absorption leading to acidification of the urine and uric acid crystallization. The presence of a low urine pH should alert the clinician to the increased risk of nephrolithiasis particularly in the obese, diabetic or hypertensive patient. Prevention of nephrolithiasis can be achieved in susceptible individuals either by alkalizing the urine and/or by further decreasing the uric acid content of the urine with a xanthine oxidase inhibitor such as allopurinol.Keywords
This publication has 27 references indexed in Scilit:
- An Update and Practical Guide to Renal Stone ManagementNephron Clinical Practice, 2010
- Percutaneous Nephrolithotripsy in Patients with Diabetes MellitusJournal of Endourology, 2009
- Diabetes Mellitus and the Risk of Urinary Tract Stones: A Population-Based Case-Control StudyAmerican Journal of Kidney Diseases, 2006
- Diabetes mellitus and the risk of nephrolithiasisKidney International, 2005
- The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistanceKidney International, 2004
- Insulin: new roles for an ancient hormoneEuropean Journal of Clinical Investigation, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Randomized Trial of Allopurinol in the Prevention of Calcium Oxalate CalculiThe New England Journal of Medicine, 1986
- Stability of first dissociable proton of uric acidJournal of Chemical & Engineering Data, 1974